Drug Recall Enforcement Report Class II voluntary initiated by Sandoz Inc, originally initiated on 09-05-2025 for the product Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10. The product was recalled due to cgmp deviations: temperature excursion during transportation.. The product was distributed nationwide and the recall is currently ongoing.
Field Name |
Field Value |
Event ID |
97549 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number |
D-0651-2025 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification |
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern |
Nationwide in the USA What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description |
Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10. |
Reason For Recall |
cGMP deviations: Temperature excursion during transportation. What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity |
263 vials Product Quantity The amount of product subject to recall. |
Voluntary Mandated |
Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date |
09-24-2025 |
Recall Initiation Date |
09-05-2025 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification |
Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type |
Drugs |
Recalling Firm |
Sandoz Inc |
Code Info |
Lot # 110459 exp. date 02/28/2027 Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Recalled NDC Packages |
0781-3528-75; 0781-3528-10; 0781-3529-70; 0781-3529-10; 0781-3530-80; 0781-3530-10 |
Status |
Ongoing |
Recalled Products
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Product Type |
0781-3528 | Cyclophosphamide | Cyclophosphamide | Injection, Solution, Concentrate | Intravenous | Sandoz Inc | Human Prescription Drug |
0781-3529 | Cyclophosphamide | Cyclophosphamide | Injection, Solution, Concentrate | Intravenous | Sandoz Inc | Human Prescription Drug |
0781-3530 | Cyclophosphamide | Cyclophosphamide | Injection, Solution, Concentrate | Intravenous | Sandoz Inc | Human Prescription Drug |